We are invested in a unique, Specialty Pharma/Nutritional Supplement, technology development company with substantial amounts of patented, and patent pending, intellectual property focused on the research advancement of a specific tobacco alkaloid "anatabine" that has major anti-inflammatory effect in vitro and in vivo to the mammalian species.
Simply put: Anatabine is a new, novel, never before discovered, potent anti-inflammatory w/ an excellent safety profile. Truth: Irrefutable "N'uff said"
They have put a "patent blanket" over the synthesis of anatabine, the material composition of an ingestible delivery device (ie anatabloc), use, as an MOAI, and they are patent pending for use for various disease states (thyroiditis, diabetes, cancer, etc).
They have expressed they are working on a pharmaceutical variant (the isomer) and given their experience, you can logically and safely infer that they will eventually have a new molecular composition of matter patent, which is likely, also going to include intellectual property for "use".(Can you say Alzheimer's). (Within a year)
They have years of pre-clinical lab work on Anatabine (Since 2007), which includes toxicity, geno toxicity, rat toxicity, pregnant rabbit studies. etc. A typical 2 year cycle of "GLP" (Who knows what that means? :). This was followed by substantial human analysis, as the alkaloid originated in a nutritional supplement associated with smoking prevention. They have since conducted numerous peer reviewed (4) Preclinical animal studies for Alzheimer's, MS, Thyroditis, and STAT3/NF-Kb Phosphorylation (Major Anti-inflammatory Effects), and have follow up work for Inflammatory Bowel Syndrome and TBI (Traumatic Brain Injury) They have significant human analysis (originated through their anti-smoking initiatives) that has evolved into human clinical work currently with Alzheimers, Rossacea (topical cream), HsCRP (Inflammation Tests) and Hashimoto's Thyroiditis.
The publication of human clinical data (150 Patients) for Thyroiditis is imminent. Any day........ Read the press releases and the Q. Go to clinical trial.gov. Irrefutable. They told you in January, and they reconfirmed in Aug. They have reversed the #1 auto-immunce disease in the USA. This has never been done before and their are 20mn Americans and over 50mn worldwide, who have the disease. There is no cure.
They have developed this compound as a nutraceutical. It works as an anti-inflammatory and you can buy this today. Ask Freddy Couples.
They have $15mn Cash, $25mn of exercisable, in the money warrants, are generating $10-$15mn run rate w/ GNC revenues, and will be profitable next year.
You can scream all you want about management and governor's scandals, but JW is a true entreprenneur, complete with his ideosyncracies, but he has surrounded himself with the President of the Harvard Law School Alumni Association to protect the company legally. Also, for regulatory development and advancement of the science, STAR has Curtiss Wright , former US FDA Deputy Director, along with Ryan Lanier, Johns Hopkins, pedigree, the smartest brain chemist in the world, Michael Mullan and the current Director of Endocrinology of Johns Hopkins, all working on the emergence of this compound and what it can do for the world.
Technically, the stock looks great. The 50 day, just crossed upward to the 200 day, a pennant formation will not last forever, bollinger bands, narrowing, and you have 30mn shares short, and their volume has dried up. There are no sellers. Also, the company has been talking to Institutional Investors over the last year, and everyone is waiting for the human proof of concept data (ie Thyroiditis Data) Any day from a major scientific publication near you. (Alzheimers data in the spring)
Apart from Drum's pump from 2012......... where he had no supportive facts....... We do today. Stock is ready to explode.....................
ALL OF THIS IS IRREFUTABLE.......... NOW IS THE TIME TO ACCUMULATE ALL YOU CAN...................................
No one can stop it. It is worth a fortune. STSI is worth a fortune and we are going to see this baby born within the next 30-60 days.
Sentiment: Strong Buy
" STSI is worth a fortune and we are going to see this baby born within the next 30-60 days."
Speaking from the option side of the stock, the above statement implies that the best option series to speculate with would be the Jan 2014 series and beyond. The November series is probably cutting it too close. But what strike price to buy?
Right now the cheapest call would be the Jan 2014 3.0 call for 10 cents, with the Jan 2014 3.5 - 7.0 strikes being less than that. I'm having a hard time wrapping my head around where the pps would go when the thyroid study presumably comes out. Perhaps a small pop, but then as the impact of the study begins to hit home, it would head higher still .... but also depending on how many fake shares the shorts would throw at it to keep the pps down.
So, if "30-60 days" is for real, then one could turn a nice profit by buying some long-dated calls. I'm not ready to pull the trigger on this idea yet simply because I've heard something similar to "30-60 days" far too often on this board, with no follow-up results.
I hope Felix is on the money with his post. It would be great for all thryoidits sufferers. That, for me, is the main reason for believing in Abloc and STSI.
Even fools like Chipper here are all too quick to believe some random posters poorly written and exaggerated pump piece. If a short wrote this, based on Chippy's past behavior, he would be all over the FACT that Felix is a new ID to this board. But apparently Chippy's bias is too strong and he only bashes those who are negative.
Sentiment: Strong Sell
Flexhose, Flex-goof-off or whoever you are...I hate to burst to your bubble. I don't know how long it took you to write your post, or who wrote it for you and where you got your information.....but sounds to me like it's written by : The Charlatan Patrick Cox. If if I were a betting man, I'd bet he wrote this peace of non sense.
Amicus humani and animali generis
Joe, While you do seem one of the more intelligent company critics, your post here is merely an ad hominem attack. And while attacking the character of the writer does carry rhetorical weight, it doesn't address what is presented as facts.
Patrick Cox is a great researcher, and an excellent writer. I recommend his new letter, published with John Mauldin. Use technical analysis to choose entry and exit points. Don't just buy on the wave of excitement generated by Patrick's insights into the technology. If you do that there's a good chance you will be under water for a time, maybe a long time. So, be cautious about buying just because Patrick thinks a technology is great, but pay serious attention to his research. It will pay off.